Literature DB >> 1986688

Silicosis, chronic airflow limitation, and chronic bronchitis in South African gold miners.

R L Cowie1, S K Mabena.   

Abstract

In a cross-sectional study of a working population of black South African gold miners, 1,197 men were studied with respiratory and occupational questionnaires, lung function tests, and chest radiographs. The study was designed to examine the effects of silicosis on respiratory symptoms and lung function. A total of 857 men with chronic, simple silicosis and 340 men without silicosis were included in the sample. Other determinants of lung disease including the duration and intensity of underground dust exposure and tobacco smoking were also examined. Three distinct pulmonary disorders could be discerned: silicosis-associated pulmonary dysfunction with dyspnea on effort; chronic airflow limitation, which was related to the duration of underground exposure; and a chronic bronchitic symptom complex, which reflected the intensity of dust exposure in the workplace. Chronic, uncomplicated silicosis was found to be associated with significant loss of lung function, and all of the measured indices, FVC, FEV1, FEV1/FVC%, maximal midexpiratory flow rate (MMEF), and lung diffusion for carbon monoxide measured by the single-breath method (DLCO) were reduced. When comparing men with Category 3/3 nodule profusion with men without silicosis, reductions of FVC of 351 ml, FEV1 of 447 ml, MMEF of 1.04 L/s, and DLCO of 4.7 ml/min/mm Hg (p = 0.0001) were detected after controlling for age, height, the direct effects of the underground environment, and tobacco smoking. Dyspnea on effort was more common in the men with silicosis (p less than 0.001).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1986688     DOI: 10.1164/ajrccm/143.1.80

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  19 in total

1.  Increased risk of obstructive pulmonary disease in tunnel workers.

Authors:  B Ulvestad; B Bakke; E Melbostad; P Fuglerud; J Kongerud; M B Lund
Journal:  Thorax       Date:  2000-04       Impact factor: 9.139

2.  Cumulative exposure to dust causes accelerated decline in lung function in tunnel workers.

Authors:  B Ulvestad; B Bakke; W Eduard; J Kongerud; M B Lund
Journal:  Occup Environ Med       Date:  2001-10       Impact factor: 4.402

3.  Loss of lung function associated with exposure to silica dust and with smoking and its relation to disability and mortality in South African gold miners.

Authors:  E Hnizdo
Journal:  Br J Ind Med       Date:  1992-07

4.  A simple diagnostic model for ruling out pneumoconiosis among construction workers.

Authors:  Eva Suarthana; Karel G M Moons; Dick Heederik; Evert Meijer
Journal:  Occup Environ Med       Date:  2007-04-04       Impact factor: 4.402

5.  Lung function in asphalt pavers: a longitudinal study.

Authors:  Bente Ulvestad; Britt Grethe Randem; Øivind Skare; Trond Mogens Aaløkken; Georg Karl Myranek; Karine Elihn; May Brit Lund
Journal:  Int Arch Occup Environ Health       Date:  2016-10-08       Impact factor: 3.015

Review 6.  Chronic obstructive pulmonary disease due to occupational exposure to silica dust: a review of epidemiological and pathological evidence.

Authors:  E Hnizdo; V Vallyathan
Journal:  Occup Environ Med       Date:  2003-04       Impact factor: 4.402

Review 7.  Occupational and chronic obstructive pulmonary disease (COPD)

Authors:  D J Hendrick
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

8.  Association of years of occupational quartz exposure with spirometric airflow limitation in Norwegian men aged 30-46 years.

Authors:  S Humerfelt; G E Eide; A Gulsvik
Journal:  Thorax       Date:  1998-08       Impact factor: 9.139

9.  Respiratory symptoms and lung function impairment in underground gold miners in ghana.

Authors:  Fy Bio; S Sadhra; C Jackson; Ps Burge
Journal:  Ghana Med J       Date:  2007-06

10.  Association of silicosis, lung dysfunction, and emphysema in gold miners.

Authors:  R L Cowie; M Hay; R G Thomas
Journal:  Thorax       Date:  1993-07       Impact factor: 9.139

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.